ABL1 and acute lymphoblastic leukemia: In addition, the cell of origin is another potential factor in disease variability highlighted by the fact that transplantation of a late onset CML like disease driven by p210 BCR-ABL in a BM transduction/transplant model led to not only myeloid disease, but also B and T ALL (54).